International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 6ISH - Hero Image 8Suported by MedtronicISH - Hero Image 9ISH - Hero Image 14ISH - Hero Image 15ISH - Hero Image 16ISH - Hero Image 17ISH - Hero Image 18Suported by OmronISH - Hero Image 19ISH - Hero Image 20ISH - Hero Image 21ISH - Hero Image 22ISH - Hero Image 23Suported by Servier

Latest News

  • ISH Global Hypertension Practice Guidelines

    Information and resources related to the 2020 ISH Global Hypertension Practice Guidelines

    Read More 27/04/2020

  • Update on ISH General Meeting

    Online General Meeting Planned for October 2020

    Read More 08/04/2020

  • Postponement of MMM 2020

    It is with reluctance and sadness that, due to the global impact of the COVID-19 pandemic, the May Measurement Month (MMM) Global Project Team has made the decision that MMM20 should not take place this year.

    We hope that volunteers will understand and support this decision. We look forward to planning MMM21 together.

    Read More 01/04/2020

  • Renin-Angiotensin System Blockers and the COVID-19 Pandemic

    Renin-Angiotensin System Blockers and the COVID-19 Pandemic

    At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

    A.H. Jan Danser, Murray Epstein, Daniel Batlle

    Read More 26/03/2020

  • Joint Meeting ESH-ISH 2020 - NEW DATES

    Dear Colleagues,

    The organizing committee of the 2020 ESH-ISH Joint Meeting in Glasgow, would like to inform you that in view of the global unprecedented situation related to COVID-19, the ESH-ISH Joint Meeting, has been rescheduled to April 11-14, 2021.

    Read More 23/03/2020

  • A statement from the International Society of Hypertension on COVID-19

    The International Society of Hypertension (ISH) is aware of concern raised by speculation, which was amplified by the media and which suggested that hypertension (raised blood pressure) increases susceptibility to infection with COVID-19. Further speculation reportedly suggested that two commonly used classes of blood pressure lowering agents (ACE-Inhibitors and Angiotensin Receptor Blockers (ARBs)) may worsen the outcome for those who are infected with COVID-19 (1).

    The ISH completely endorses the content of two recent statements made by the Council on Hypertension of the European Society of Cardiology and the European Society of Hypertension (2,3) both of which made clear that there is no good evidence to change the use of ACE-inhibitors or ARBs for the management of raised blood pressure in the context of avoiding or treating COVID-19 infection.

    Read More 16/03/2020

  • ISH Hypertension News

    We are delighted to share with you the March 2020 issue of ISH Hypertension News.

    ISH Hypertension News is available online @ http://ish-world.com/news/a/hypertensionnews/, ISSN: 2520-2782

    Read More 13/03/2020

  • ISH Awards Announced

    New Awards Supported by the ISH Mentoring and Training Committee and the ISH Women in Hypertension Research Committee Announced.

    Read More 24/02/2020

  • Fundamentals for Implementing a Hypertension Program in Resource-Constrained Settings

    ISH-supported Online Course aims to help program managers and implementers in designing, planning, and implementing a hypertension control program.

    Read More 24/02/2020

  • CALL FOR 2020 ISH AWARD NOMINATIONS

    Award Nomination Deadline: Sunday 15th March 2020

    NOMINATIONS SHOULD BE SENT TO:
    Professor George Stergiou, Chair, ISH Awards Committee
    c/o THE ISH SECRETARIAT
    Email: secretariat@ish-world.com

    Read More 13/02/2020

Latest Tweets:

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.